Tenofovir Disoproxil Fumarate(Tdf) Tablets 300 mg Suppliers & Bulk Manufacturers
Available Forms: Oral tablets
Available Strengths: 300 mg
Reference Brands: Viread (EU & US), Truvada (India)
Category: Hepatitis
Tenofovir Disoproxil Fumarate (TDF) is a 300 mg oral antiviral used to treat chronic Hepatitis B and HIV-1 infections. It inhibits viral reverse transcriptase, reducing viral replication and disease progression. Marketed as Viread®, it is approved by FDA and EMA and widely used in the US and EU. TDF is a key drug for pharma B2B suppliers and healthcare professionals managing viral infections.
Product Description:
Tenofovir Disoproxil Fumarate (TDF) is a potent nucleotide reverse transcriptase inhibitor used to treat chronic Hepatitis B virus (HBV) infection and HIV-1. Available as oral tablets at 300 mg strength, TDF effectively blocks viral replication by inhibiting viral reverse transcriptase enzymes, reducing viral load and preventing disease progression. Marketed under the brand name Viread® by Gilead Sciences, it is approved by the US FDA and EMA. Widely prescribed in both the EU and US, Tenofovir Disoproxil Fumarate is essential for pharma B2B suppliers and healthcare providers managing viral hepatitis and HIV therapies.
Tenofovir Disoproxil Fumarate(Tdf) Tablets — third party manufacturing & bulk supply
Tenofovir Disoproxil Fumarate(Tdf) Tablets 300 mg is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:
What to include when you enquire
- Destination market — determines which manufacturers hold the right site-level approvals
- First order quantity and estimated annual volume
- Whether you need a registration dossier or the product is already registered
- Packaging, labelling and language requirements
- Incoterms and required shelf life
Manufacturers of Tenofovir Disoproxil Fumarate(Tdf) Tablets listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding. Narcotic drugs and controlled substances are supplied strictly against valid import and export permits issued by the competent authorities.
Request a quote for Tenofovir Disoproxil Fumarate(Tdf) Table... →The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Frequently Asked Questions
Tenofovir Disoproxil Fumarate (TDF) is used to treat HIV-1 infection in combination with other antiretroviral agents and to manage chronic hepatitis B virus (HBV) infection in adults.
TDF is a prodrug of tenofovir, designed to improve oral bioavailability and deliver active tenofovir to target cells, inhibiting viral replication.
Common trade names include Viread, Truvada (as combination with emtricitabine), and Atripla (as combination with efavirenz and emtricitabine).
TDF is manufactured by Gilead Sciences.
The generic name is Tenofovir Disoproxil Fumarate.
Brand names include Viread, Truvada, and Atripla.
TDF is manufactured in the USA and distributed globally, including the USA, EU, India, Japan, and other regions.
Related Products
Ombitasvir/Paritaprevir/Ritonavir + Dasabuvir
Strength:
Ombitasvir 12.5 mg / Paritaprevir 75 mg / Ritonavir 50 mg (tablet)+ Dasabuvir 250 mg (tablet)
Form: Tablet
Reference Brands: Viekira Pak® (US); Viekirax® + Exviera® (EU)
View DetailsRibavirin
Strength:
Tablet:200 mg, 400 mg, 600mg; Capsule:200 mg; Solution:40 mg/mL
Form: Tablets, Capsules and Oral Solution
Reference Brands: Rebetol®, Copegus®, Virazole®(EU & US)
View DetailsAdefovir Dipivoxil
Strength:
10 mg
Form: Oral tablets
Reference Brands: Hepsera® (EU & US)
View DetailsTenofovir Alafenamide (Taf)
Strength:
25 mg TAF per tablet
Form: Tablet
Reference Brands: Vemlidy (EU & US), Genvoya (India)
View DetailsQuick Response Guaranteed | Verified Suppliers